MedTrace Logo

Evaluation of Libramed in Obesity Treatment

NCT03537235 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-05-30

No results posted yet for this study

Summary

Randomized, double-blind, placebo-controlled study aimed at evaluating the effects of a 3-months treatment with Policaptil Gel Retard on postprandial incretin hormones release and satiety in obese women

Conditions

  • Overweight and Obesity

Interventions

DEVICE

Libramed

DEVICE

Placebo

Sponsors & Collaborators

  • Sprim Advanced Life Sciences

    collaborator OTHER

  • Aboca Spa Societa' Agricola

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-29
Primary Completion
2019-02-22
Completion
2019-02-22

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03537235 on ClinicalTrials.gov